Bayesian hierarchical models combining different study types and adjusting for covariate imbalances: a simulation study to assess model performance
- PMID: 22016772
- PMCID: PMC3189931
- DOI: 10.1371/journal.pone.0025635
Bayesian hierarchical models combining different study types and adjusting for covariate imbalances: a simulation study to assess model performance
Abstract
Background: Bayesian hierarchical models have been proposed to combine evidence from different types of study designs. However, when combining evidence from randomised and non-randomised controlled studies, imbalances in patient characteristics between study arms may bias the results. The objective of this study was to assess the performance of a proposed Bayesian approach to adjust for imbalances in patient level covariates when combining evidence from both types of study designs.
Methodology/principal findings: Simulation techniques, in which the truth is known, were used to generate sets of data for randomised and non-randomised studies. Covariate imbalances between study arms were introduced in the non-randomised studies. The performance of the Bayesian hierarchical model adjusted for imbalances was assessed in terms of bias. The data were also modelled using three other Bayesian approaches for synthesising evidence from randomised and non-randomised studies. The simulations considered six scenarios aimed at assessing the sensitivity of the results to changes in the impact of the imbalances and the relative number and size of studies of each type. For all six scenarios considered, the Bayesian hierarchical model adjusted for differences within studies gave results that were unbiased and closest to the true value compared to the other models.
Conclusions/significance: Where informed health care decision making requires the synthesis of evidence from randomised and non-randomised study designs, the proposed hierarchical Bayesian method adjusted for differences in patient characteristics between study arms may facilitate the optimal use of all available evidence leading to unbiased results compared to unadjusted analyses.
Conflict of interest statement
Figures

Similar articles
-
The importance of adjusting for potential confounders in Bayesian hierarchical models synthesising evidence from randomised and non-randomised studies: an application comparing treatments for abdominal aortic aneurysms.BMC Med Res Methodol. 2010 Jul 9;10:64. doi: 10.1186/1471-2288-10-64. BMC Med Res Methodol. 2010. PMID: 20618973 Free PMC article.
-
Hierarchical Bayesian modeling of heterogeneous outcome variance in cluster randomized trials.Clin Trials. 2024 Aug;21(4):451-460. doi: 10.1177/17407745231222018. Epub 2024 Jan 10. Clin Trials. 2024. PMID: 38197388 Free PMC article.
-
Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment.Pharm Stat. 2025 Mar-Apr;24(2):e2443. doi: 10.1002/pst.2443. Epub 2024 Oct 24. Pharm Stat. 2025. PMID: 39444356
-
Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.Health Technol Assess. 2001;5(33):1-56. doi: 10.3310/hta5330. Health Technol Assess. 2001. PMID: 11701102 Review.
-
Bayesian methods in health technology assessment: a review.Health Technol Assess. 2000;4(38):1-130. Health Technol Assess. 2000. PMID: 11134920 Review.
Cited by
-
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis.Syst Rev. 2018 Nov 14;7(1):191. doi: 10.1186/s13643-018-0854-y. Syst Rev. 2018. PMID: 30428932 Free PMC article.
-
Principles of Experimental Design for Big Data Analysis.Stat Sci. 2017 Aug;32(3):385-404. doi: 10.1214/16-STS604. Stat Sci. 2017. PMID: 28883686 Free PMC article.
-
Classifying information-sharing methods.BMC Med Res Methodol. 2021 May 22;21(1):107. doi: 10.1186/s12874-021-01292-z. BMC Med Res Methodol. 2021. PMID: 34022810 Free PMC article.
-
Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.Syst Rev. 2015 Nov 5;4:147. doi: 10.1186/s13643-015-0133-0. Syst Rev. 2015. PMID: 26537988 Free PMC article.
-
Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.Syst Rev. 2017 Oct 10;6(1):196. doi: 10.1186/s13643-017-0588-2. Syst Rev. 2017. PMID: 29017563 Free PMC article.
References
-
- Prevost TC, Abrams KR, Jones DR. Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening. Stat Med. 2000;19:3359–76. - PubMed
-
- Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res. 2001;10(4):277–303. - PubMed
-
- Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, et al. Evaulating non-randomised intervention studies. Health Technol Assess. 2003;7(27) - PubMed
-
- McCarron CE, Pullenayegum EM, Thabane L, Goeree R, Tarride JE. The importance of adjusting for potential confounders in Bayesian hierarchical models synthesising evidence from randomised and non-randomised studies: an application comparing treatments for abdominal aortic aneurysms. BMC Med Res Methodol. 2010;10:64. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources